Hospira Desferrioxamine Mesilate 500 mg Powder for Injection vial

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

desferrioxamine mesilate, Quantity: 500 mg

Disponible desde:

Hospira Australia Pty Ltd

Designación común internacional (DCI):

desferrioxamine mesilate

formulario farmacéutico:

Injection

Composición:

Excipient Ingredients:

Vía de administración:

Intraperitoneal, Intravenous, Intramuscular, Subcutaneous

Unidades en paquete:

10 x 10 mL vials

clase:

Medicine Listed (Export Only)

tipo de receta:

(S1) This Schedule is intentionally blank

indicaciones terapéuticas:

Desferrioxamine mesilate is a binding agent for iron and aluminium. Desferrioxamine mesilate is used to remove excess iron or aluminium from the body in patients with conditions such as iron poisoning, thalassemia (a heredity type of anemia) haemochromatosis (a disorder of iron metabolism) and aluminium overload due to kidney failure. It may also be used to diagnose iron storage disease and some types of chronic anemias or aluminium overload in some patients.

Resumen del producto:

Visual Identification: A white to cream powder or lyophilised plug; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Listed (Export Only)

Fecha de autorización:

2007-04-16